Merck & Co. Short-Term Investments decreased by 100.0% to $0.00 in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $447.00M to $0.00. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher levels indicate strong liquidity and significant 'dry powder' for acquisitions or R&D, while lower levels might suggest cash is being deployed into long-term projects or shareholder returns.
Highly liquid assets and marketable securities that are expected to be converted into cash within one year. For technolo...
Commonly compared against other cash-rich technology peers to assess capital preservation strategies and short-term solvency.
short_term_investments| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $372.00M | $453.00M | $103.00M | $498.00M | $680.00M | $718.00M | $168.00M | $252.00M | $40.00M | $50.00M | $0.00 | $447.00M | $599.00M | $615.00M | $45.00M | $0.00 |
| QoQ Change | — | — | +21.8% | -77.3% | +383.5% | +36.5% | +5.6% | -76.6% | +50.0% | -84.1% | +25.0% | -100.0% | — | +34.0% | +2.7% | -92.7% | -100.0% |
| YoY Change | — | — | — | — | — | +82.8% | +58.5% | +63.1% | -49.4% | -94.1% | -93.0% | -100.0% | +77.4% | >999% | >999% | — | -100.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.